TR200103016T2 - CDK2 önleyicileri olarak pirazolobenzodiazepinler - Google Patents

CDK2 önleyicileri olarak pirazolobenzodiazepinler

Info

Publication number
TR200103016T2
TR200103016T2 TR2001/03016T TR200103016T TR200103016T2 TR 200103016 T2 TR200103016 T2 TR 200103016T2 TR 2001/03016 T TR2001/03016 T TR 2001/03016T TR 200103016 T TR200103016 T TR 200103016T TR 200103016 T2 TR200103016 T2 TR 200103016T2
Authority
TR
Turkey
Prior art keywords
pirazolobenzodiazepines
formula
cdk2 inhibitors
cdk2
pyrazolobenzodiazepines
Prior art date
Application number
TR2001/03016T
Other languages
English (en)
Inventor
Ding Qingjie
Liu Jin-Jun
Stewart Madison Vincent
Pizzolato Giacomo
Chen Wei Chung
Michael Wovkulich Peter
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR200103016T2 publication Critical patent/TR200103016T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/22—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

R1, R2, R3 ve R4'ün burada tanimlandigi gibi oldugu formül (I)'e ait yeni pirazolobenzodiazepinler ve bunlarin farmasötik açidan kabul gören tuzlari, sikline bagli kinazlari (CDKler), özellikle de CDK2'yi önler; bunlar, hücre artisi olan bozukluklarin özellikle gögüs, kolon, akciger ve prostat tümörlerinin tedavisinde ya da kontrolünde faydali anti-proliferatif maddelerdir. (FORMÜL VAR)
TR2001/03016T 1999-04-21 2000-04-14 CDK2 önleyicileri olarak pirazolobenzodiazepinler TR200103016T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13037099P 1999-04-21 1999-04-21

Publications (1)

Publication Number Publication Date
TR200103016T2 true TR200103016T2 (tr) 2002-04-22

Family

ID=22444382

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03016T TR200103016T2 (tr) 1999-04-21 2000-04-14 CDK2 önleyicileri olarak pirazolobenzodiazepinler

Country Status (33)

Country Link
US (3) US6440959B1 (tr)
EP (1) EP1185529B1 (tr)
JP (1) JP3746680B2 (tr)
KR (1) KR100481757B1 (tr)
CN (2) CN1196703C (tr)
AR (1) AR023542A1 (tr)
AT (1) ATE279413T1 (tr)
AU (1) AU768667B2 (tr)
BR (1) BR0009887A (tr)
CA (1) CA2367704C (tr)
CO (1) CO5170444A1 (tr)
CZ (1) CZ20013738A3 (tr)
DE (1) DE60014893T2 (tr)
DK (1) DK1185529T3 (tr)
ES (1) ES2228522T3 (tr)
HK (1) HK1046278B (tr)
HR (1) HRP20010742A2 (tr)
HU (1) HUP0300318A3 (tr)
IL (1) IL145764A0 (tr)
JO (1) JO2248B1 (tr)
MA (1) MA26782A1 (tr)
NO (1) NO20015065L (tr)
NZ (1) NZ514523A (tr)
PE (1) PE20010054A1 (tr)
PL (1) PL200933B1 (tr)
PT (1) PT1185529E (tr)
RU (1) RU2249593C2 (tr)
SI (1) SI1185529T1 (tr)
TR (1) TR200103016T2 (tr)
TW (1) TW585866B (tr)
WO (1) WO2000064900A1 (tr)
YU (1) YU73101A (tr)
ZA (1) ZA200108016B (tr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6520951B1 (en) 1996-09-13 2003-02-18 Scimed Life Systems, Inc. Rapid exchange catheter with detachable hood
PT1443937E (pt) * 2001-11-13 2008-09-23 Ortho Mcneil Janssen Pharm 1,4-benzodiazepinas substituídas e as suas utilizações para o tratamento de cancro
FR2847253B1 (fr) * 2002-11-19 2007-05-18 Aventis Pharma Sa Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
ES2545666T3 (es) * 2003-02-27 2015-09-14 Abbvie Inc. 5,10-Dihidro-11H-dibenzo[b,e][1,4]diazepin-11-ona como inhibidores de quinasa
WO2006040036A1 (en) * 2004-10-13 2006-04-20 F. Hoffmann-La Roche Ag Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
BRPI0617252A2 (pt) * 2005-10-14 2011-07-19 Hoffmann La Roche regime de administração para benzodiazepina 5-2-clorofenil)-1,2-diidro-7-flìor-8-metóxi-3-metil-pira zolo [3,4-b] [1,4]
CA2657347C (en) 2006-07-10 2014-11-18 Paion Uk Limited Short-acting benzodiazepine salts and their polymorphic forms
KR20100073454A (ko) * 2008-12-23 2010-07-01 국립암센터 트란스글루타미나제 억제제로 사용되는 신규한 피라졸로디아제핀계 화합물, 이의 제조방법 및 이를 포함하는 조성물
EP2305647A1 (en) * 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
UA117342C2 (uk) * 2012-02-02 2018-07-25 Сенекс Біотекнолоджи Інк. Селективні інгібітори cdk8/cdk19 та їх застосування як протиметастатичних та хіміопрофілактичних засобів у способах лікування раку
CN102603743B (zh) * 2012-02-24 2014-05-28 南京天易生物科技有限公司 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途
CN103288828A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-6H-吲哚并[2,1-c][1,4]-苯并二氮杂卓的方法
CN103288830A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓的方法
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN106608877B (zh) * 2015-10-21 2018-11-13 新发药业有限公司 一种依鲁替尼中间体4-氨基-3-（4-苯氧基）苯基-1H-吡唑并[3,4-d]嘧啶的制备方法
JP7139323B2 (ja) * 2016-11-01 2022-09-20 エフ．ホフマン－ラ ロシュ アーゲー Ｃｎｓ関連疾患を処置するための１，３－ジヒドロ－１，４－ベンゾジアゼピン－２－チオン
LT3447056T (lt) * 2016-12-13 2025-07-10 Transthera Sciences (Nanjing), Inc. Daugiafunkcių kinazių inhibitoriaus junginys ir jo kristalinė forma bei naudojimas
CN109020980B (zh) * 2017-06-09 2020-11-20 华东师范大学 一类抗肿瘤作用的吡唑并嘧啶二氮*衍生物
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223558A1 (en) * 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
TW202115024A (zh) 2019-08-14 2021-04-16 美商英塞特公司 作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
AU2020364007A1 (en) 2019-10-11 2022-04-28 Incyte Corporation Bicyclic amines as CDK2 inhibitors
KR20230008792A (ko) * 2020-05-08 2023-01-16 트랜스테라 사이언시즈 (난징), 인크. 항종양 화합물의 합성방법 및 그 중간체
WO2022113003A1 (en) 2020-11-27 2022-06-02 Rhizen Pharmaceuticals Ag Cdk inhibitors
WO2022149057A1 (en) 2021-01-05 2022-07-14 Rhizen Pharmaceuticals Ag Cdk inhibitors
AU2022271290A1 (en) 2021-05-07 2023-11-23 Kymera Therapeutics, Inc. Cdk2 degraders and uses thereof
KR20240006610A (ko) * 2021-05-10 2024-01-15 트랜스테라 사이언시즈 (난징), 인크. 다중-키나제 억제제의 제약 조성물 및 용도
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
WO2024030399A2 (en) * 2022-08-02 2024-02-08 Lab1636, Llc Use of a gaba-a pam for reduction of tactile hypersensitivity
WO2026024674A1 (en) 2024-07-22 2026-01-29 Genesis Therapeutics, Inc. Methods of treating skp2-associated cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071092A1 (en) * 1991-06-14 1992-12-15 Roger M. Freidinger 1,4-benzodiazepines with 5-membered heterocyclic rings
US6251911B1 (en) 1996-10-02 2001-06-26 Novartis Ag Pyrimidine derivatives and processes for the preparation thereof
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers

Also Published As

Publication number Publication date
PL354405A1 (en) 2004-01-12
IL145764A0 (en) 2002-07-25
YU73101A (sh) 2004-05-12
AU768667B2 (en) 2003-12-18
PL200933B1 (pl) 2009-02-27
CN1279029C (zh) 2006-10-11
JP3746680B2 (ja) 2006-02-15
PE20010054A1 (es) 2001-02-07
CO5170444A1 (es) 2002-06-27
JO2248B1 (en) 2004-10-07
ES2228522T3 (es) 2005-04-16
DK1185529T3 (da) 2005-02-07
CZ20013738A3 (cs) 2002-08-14
WO2000064900A1 (en) 2000-11-02
AR023542A1 (es) 2002-09-04
US6838558B2 (en) 2005-01-04
JP2002543081A (ja) 2002-12-17
HUP0300318A2 (hu) 2003-06-28
TW585866B (en) 2004-05-01
KR20010112435A (ko) 2001-12-20
RU2249593C2 (ru) 2005-04-10
US6440959B1 (en) 2002-08-27
SI1185529T1 (en) 2005-02-28
HRP20010742A2 (en) 2002-12-31
EP1185529B1 (en) 2004-10-13
KR100481757B1 (ko) 2005-04-11
CA2367704C (en) 2008-06-17
US20020183514A1 (en) 2002-12-05
US6916923B2 (en) 2005-07-12
ZA200108016B (en) 2003-03-26
HK1046278A1 (en) 2003-01-03
EP1185529A1 (en) 2002-03-13
US20040198976A1 (en) 2004-10-07
HUP0300318A3 (en) 2004-11-29
CN1196703C (zh) 2005-04-13
CN1348455A (zh) 2002-05-08
NO20015065D0 (no) 2001-10-18
NO20015065L (no) 2001-10-18
PT1185529E (pt) 2005-02-28
BR0009887A (pt) 2002-01-22
CA2367704A1 (en) 2000-11-02
NZ514523A (en) 2003-11-28
AU4748000A (en) 2000-11-10
ATE279413T1 (de) 2004-10-15
DE60014893T2 (de) 2005-10-13
CN1603314A (zh) 2005-04-06
DE60014893D1 (de) 2004-11-18
MA26782A1 (fr) 2004-12-20
HK1046278B (zh) 2005-08-12

Similar Documents

Publication Publication Date Title
TR200103016T2 (tr) CDK2 önleyicileri olarak pirazolobenzodiazepinler
EP0939627A4 (en) PENTAFLUOROBENZENE SULFAMIDES AND THE LIKE
BRPI0409366A (pt) compostos de pirimido
PL346797A1 (en) Arylsulfonanilide ureas
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
BR0315912A (pt) Compostos pirimìdicos com atividade antiproliferativa (ii)
TW200407326A (en) Pyrimido compounds having antiproliferative activity
BR0116323A (pt) Compostos de heterociclilindazol e -azaindazol como ligandos de 5-hidroxitriptamina-6
MY126862A (en) Purine derivatives inhibitors of tyrosine protein kinase syk
ATE378321T1 (de) Pyrazolopyrimidine
MY129809A (en) Quinazoline derivatives
MY137156A (en) Dual nk1/nk3 derivatives
BR0010220A (pt) Compostos de pirimidinona
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
BR0016553A (pt) 2-(1h-indol-3-il)-2-oxo-acetamidas com atividades antitumor
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE287886T1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
PT1147087E (pt) Feantridina-n-oxidos com actividade de inibicao de pde-iv
DE60008400D1 (de) Triazolopyrimidinderivate
DE69911017D1 (en) Arylsulfonanilid-phosphate
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DE60206599D1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
YU46302A (sh) Supstituisani piroli
BRPI0415038A (pt) derivados de imidazo (4,5-b) piridina como inibidores sem ser da sintase que podem ser induzidos